International Journal of Pharmaceutical and Phytopharmacological Research
ISSN (Print): 2250-1029
ISSN (Online): 2249-6084
Publish with eIJPPR Submission
2025   Volume 15   Issue 3

Learning Across Bioassays Without Pretending Same Biology via Context-Aware and Assay-Specific Prediction
Download PDF


, ,
  1. Department of Context-Aware Bioassay Transfer Learning, Faculty of Pharmacy, Cairo University, Cairo, Egypt.
  2. Department of Assay-Specific Molecular Prediction, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt.
Citation
Vancouver
Zayed O, Ibrahim L, Mansour A. Learning Across Bioassays Without Pretending Same Biology via Context-Aware and Assay-Specific Prediction. Int J Pharm Phytopharmacol Res. 2025;15(3):108-16. https://doi.org/10.51847/kUwS08zaQX
APA
Zayed, O., Ibrahim, L., & Mansour, A. (2025). Learning Across Bioassays Without Pretending Same Biology via Context-Aware and Assay-Specific Prediction. International Journal of Pharmaceutical And Phytopharmacological Research, 15(3), 108-116. https://doi.org/10.51847/kUwS08zaQX
Download citation:   EndNote   RIS
Article Link:
Downloads: 24
Views: 61
Abstract

Bioactivity modeling often gains statistical power by pooling assays, sharing representations, or transferring parameters across related prediction tasks. These strategies are useful, but they can quietly replace a biological question with a convenience assumption that measurements obtained under different assay conditions represent the same response variable up to noise. This methodological article argues that assay context should instead be treated as part of the prediction target whenever experimental conditions, measurement type, biological system, or provenance can alter the mapping from molecular structure to observed activity. The analysis distinguishes molecular representation from assay representation, related-task transfer from label pooling, and assay-specific prediction from universal endpoint modeling. It proposes a context-aware transfer framework in which molecular features are combined with explicit or learned assay-context information, cross-assay sharing is conditioned on estimated task relevance, and assay-specific outputs are preserved where measurements are not biologically interchangeable. The framework also treats conflicting labels, negative transfer, dataset shift, and context novelty as first-class evaluation problems rather than residual error. Its intended contribution is methodological: to organize existing evidence into a disciplined strategy for learning across bioassays without erasing meaningful heterogeneity. The proposal does not establish a universally optimal architecture, mechanistic interpretation, or prospective performance advantage. Its value therefore depends on future tests that separate chemical novelty from context novelty, compare selective against indiscriminate transfer, and assess calibration under assay families not represented during training.

Related articles:
Most viewed articles:
Naproxen in Pain and Inflammation – A Review
Vol 11 Issue 1, 2021 | Svetoslav Nikolaev Stoev
An Overview on Emulgel
Vol 9 Issue 1, 2019 | Sreevidya V.S
Volume 16
Issue 4
2026

Call for Papers
[email protected]
Issues
Associations
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (CC BY-NC-SA 4.0).

Copyright © 2026 International Journal of Pharmaceutical and Phytopharmacological Research
Authors retain copyright of their article if they are accepted for publication.